Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.03 CAD | 0.00% | 0.00% | -45.45% |
May. 15 | PharmaTher's Sairiyo Submits Clinical Trial Application in Australia For Phase 1 Study of Reformulated Cepharanthine | MT |
May. 02 | PharmaDrug Announces Directorate Changes | CI |
- Stock Market
- Equities
- PHRX Stock
- News Pharmadrug Inc.